当前位置:首页 - 行情中心 - 华熙生物(688363) - 财务分析

华熙生物

(688363)

  

流通市值:286.98亿  总市值:286.98亿
流通股本:4.82亿   总股本:4.82亿

华熙生物(688363)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润2.21亿元,每股收益0.46元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益706501.69万元,未分配利润261460.62万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产857280.58万元,负债150778.89万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入2,260,691,517.331,077,926,981.075,370,770,254.643,874,744,443.18
营业总成本1,981,640,358.55944,321,696.145,039,860,099.83,419,165,826.77
其他经营收益
营业利润261,036,071.59133,829,725.24215,939,708.29436,124,755.33
利润总额260,324,427.05133,354,931.51213,392,902.88436,569,109.98
净利润220,803,434.47101,136,170.05168,405,915.37359,049,886.13
每股收益
其他综合收益51,143,889.0814,066,443.87-23,891,534.78-1,856,452.6
综合收益总额271,947,323.55115,202,613.92144,514,380.59357,193,433.53
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,718,781,372.732,652,529,562.672,740,660,561.122,682,481,539.48
非流动资产:
非流动资产合计5,854,024,415.135,884,813,267.245,916,071,276.876,005,480,452.74
资产总计8,572,805,787.868,537,342,829.918,656,731,837.998,687,961,992.22
流动负债:
流动负债合计1,126,401,367.361,120,830,309.481,341,029,855.411,136,227,866.53
非流动负债:
非流动负债合计381,387,517.96458,742,855.2475,898,909.22498,524,864.01
负债合计1,507,788,885.321,579,573,164.681,816,928,764.631,634,752,730.54
所有者权益(或股东权益):
归属于母公司股东权益合计7,032,912,753.76,928,894,256.556,810,170,453.977,018,771,164.37
股东权益合计7,065,016,902.546,957,769,665.236,839,803,073.367,053,209,261.68
负债和股东权益合计8,572,805,787.868,537,342,829.918,656,731,837.998,687,961,992.22
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计2,495,776,822.71,206,263,154.315,885,327,340.764,179,095,693.68
经营活动现金流出小计2,277,444,564.791,229,240,195.65,320,822,206.843,905,039,429.41
经营活动产生的现金流量净额218,332,257.91-22,977,041.29564,505,133.92274,056,264.27
投资活动产生的现金流量:
投资活动现金流入小计92,684,934.2230,843,828.62678,000,683.75647,652,292.35
投资活动现金流出小计222,056,165.73101,774,198.811,139,366,368.91953,744,001.24
投资活动产生的现金流量净额-129,371,231.51-70,930,370.19-461,365,685.16-306,091,708.89
筹资活动产生的现金流量:
筹资活动现金流入小计169,980,125118,460,125149,895,777.78100,000,000
筹资活动现金流出小计215,892,485.8768,913,586.92460,414,416.69449,700,503.76
筹资活动产生的现金流量净额-45,912,360.8749,546,538.08-310,518,638.91-349,700,503.76
汇率变动对现金及现金等价物的影响12,791,476.545,343,906.67,811,616.523,481,744.29
现金及现金等价物净增加额55,840,142.07-39,016,966.8-199,567,573.63-378,254,204.09
期末现金及现金等价物余额669,332,550.44574,475,441.57613,492,408.37434,805,777.91
补充资料:
现金及现金等价物的净增加额55,840,142.07--199,567,573.63-
最新报告期:2025-09-11
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长江证券李锦,罗祎0.991.361.602025-09-11
国信证券柳旭,张峻豪0.941.131.322025-09-01
光大证券姜浩0.981.231.662025-08-28
野村东方国际证券张影秋,曾万霖0.931.381.552025-08-28
申万宏源王盼,聂霜,王立平0.941.081.262025-08-27
TOP↑